WuXi Biologics is a global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics.
Our global footprint includes sites throughout the United States, Europe, China and Singapore.
Located in the robust biopharmaceutical tristate region of New York, New Jersey and Pennsylvania, the WuXi Biologics’ Cranbury site (MFG18) focuses on biologics development and clinicalscale drug substance GMP manufacturing.